Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital Center of Martinique
About this trial
Estimating the prevalence of Helicobacter Pylori infection in newly diagnosed stomach cancers in the West-Indies will help to understand the epidemiology of this cancer, which is over-incident in the West Indies compared to France. In addition, the constitution of a biobank (tumor tissues, healthy tissues and serum) will allow to set up in a second time etiological studies to identify other risk factors in particular in connection with the exposure to environmental pollutants to adapt the prevention measures.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient over 18 years of age, residing for at least 6 months in Martinique, with a primary diagnosis of gastric cancer
Patient having read the information note and having signed the consent to participate in the study
Patient with social security coverage
Disqualifiers
Refusal to participate
Patient who could not answer the questionnaires
Patient not affiliated to a social security system
Patient not fluent in French
Trial population
Eligible patients (with a suspected endoscopic diagnosis of gastric cancer) will be selected either at the Martinique University Hospital or at the Sainte-Marie clinic during consultations or hospitalizations.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Helicobacter Pylori detection
Biological/VaccineBiopsies will be sent to the referral anatomopathology laboratory. The search for Helicobacter pylori will be performed by immunohistochemistry. An additional blood sample for serological testing will be taken during the initial workup. Additional data will be collected through a questionnaire.
Treatment groups
112 Participants
are divided into 1 treatment groupGroup A: Helicobacter Pylori detection1 intervention
Trial outcomes
Primary outcomes
1
Estimation of the prevalence of Helicobacter pylori
Helicobacter Pylori has detected by immunohistochemistry in the stomach of patients with gastric cancer.
Time frame
At baselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov